.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Maryland, Momenta has shown fluctuating performance in the Concentrates category over the past few months. Starting at rank 24 in July 2025, the brand slipped to 28th place by August, and subsequently fell out of the top 30 by September. This decline in ranking indicates a potential struggle to maintain market presence in Maryland's competitive Concentrates sector. Despite this, the brand's sales figures reveal an interesting trend: while sales decreased from July to August, the absence of ranking data for September and October suggests a need for further analysis to understand whether this is a temporary dip or part of a larger trend.
The absence of Momenta in the top 30 rankings for September and October in Maryland's Concentrates category could be cause for concern, as it highlights a significant drop in market visibility. Such a decline in ranking could impact the brand's overall market strategy and requires close monitoring to determine if adjustments are needed. The initial ranking in July suggests that Momenta had a foothold in the market, but the subsequent drop points to increased competition or shifting consumer preferences. Understanding these dynamics is crucial for assessing the brand's future prospects in Maryland's cannabis market.
Competitive Landscape
In the Maryland concentrates market, Momenta has experienced a notable shift in its competitive positioning over the past few months. Initially ranked 24th in July 2025, Momenta slipped to 28th by August and has not appeared in the top 20 since, indicating a downward trend in its market presence. This decline is contrasted by the performance of competitors such as Roll One / R.O., which maintained a strong presence with a rank of 17th in July and 18th in September, and CULTA, which emerged in September at 19th. Meanwhile, Amber entered the rankings in October at 25th, suggesting a competitive market landscape. Additionally, Phas3 appeared in October at 28th, closely trailing Momenta's previous rank. These dynamics highlight the increasing competition Momenta faces, underscoring the need for strategic adjustments to regain and enhance its market share.
Notable Products
In October 2025, the top-performing product from Momenta was the Sour Gremlin RSO Syringe (1g) in the Concentrates category, maintaining its number one rank from the previous two months with sales of 57 units. Soul Safari RSO Syringe (1g) held its position as the second top-selling product, consistent with its rank in August, despite a slight drop in sales. Romance Runtz RSO Syringe (1g) climbed to the third spot, improving from its fifth-place rank in September. White 99 RSO Syringe (1g) entered the rankings at fourth place, showing a notable presence after being absent in previous months. Finally, MAC V2 RSO Syringe (1g) slipped to the fifth position, marking a decline from its fourth-place rank in September.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
